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Gaucher disease (GD) type 1 is the most common lysosomal storage disorder due to beta glucocerebrosidase deﬁciency leading
to an abnormal accumulation of its substrate, glucocerebroside, in the mononuclear phagocyte system. The disease presentation
is usually characterized by signs and symptoms related to hypersplenism, such as splenomegaly, anaemia, thrombocytopenia and
leucopenia. Skeletal disease may occur later for the inﬁltration of bone marrow by macrophages inﬁltration and bone resorption:
bone involvement may be heterogeneously manifested by symptoms ranging from bone crisis to avascular necrosis, osteoporosis
and defect in remodeling of long bones. Herein, we report a patient in whom the osteoarticular involvement has been the only
symptom of the disease stressing that this unusual presentation of GD has prompted a wide diﬀerential diagnosis with more
commonforms of coxitis.
1.CaseReport
A 9-year-old girl, born from healthy and unrelated parents,
was admitted because of the abrupt occurrence of hip pain
and limping.
The patient’smedical history was notsigniﬁcant: namely,
neither previous trauma or infections have been reported.
At admission, she was extremely suﬀering, pale, and sweaty,
albeit apyrexial and normotensive.
Her right hip joint was painful and passive, and active
motion of the joint was completely restricted; walking was
impossible so the patient was using a wheel-chair. On
physical examination no other ﬁndings were present.
Standard X-ray of the coxofemoral joints led to rule out
major traumatic lesions and bone proﬁle abnormalities.
Ultrasound evaluation showed the presence of intra-
articular ﬂuid eﬀusion at right hip and synovial thickening.
Acutephasereactantswere slightlyincreased: erythrocyte
sedimentation rate was 62mm/1h and C-reactive-protein
level 1.24mg/dL (normal values < 0,46mg/dL). Total and
diﬀerential white cell count and haemoglobin level were
within the normal range; platelets count was 156 × 103
(normal values > 150 × 103).
Upon this basis the diagnosis of acute coxitis has
been considered. Indirect serodiagnosis for the com-
mon pathogens causing reactive arthritis (i.e., Yersinia,
Shigella, Salmonella, Campylobacter jejuni, Parvovirus B19,
Echovirus, Coxsackievirus, CMV, EBV, mycoplasma) as well
as throat culture and streptococcal antibody titers were
negative. Mantoux tuberculin reaction was also negative.
Antinuclear autoantibodies, rheumatoid factor, and HLA
B 27 haplotype were negative too.
The clinical picture was characterized by the presence
of intense right hip pain unresponsive to non steroid
anti-inﬂammatory drugs: it was therefore started treatment
with analgesics and opioids such as tramadol administered
by elastomeric device with the guidance of a consultant
anaesthesiologist which seemed to be partially eﬀective.2 Arthritis
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Figure 1: Coronal TSE T2 sequence (TR 2700/TE 70) with fat saturation. Presence of joint eﬀusion in the right coxofemoral joint (arrow)
with evidence of marked bone marrow hyperintensity of the femoral head and neck related to bone marrow oedema (arrowhead).
The most common diseases that cause severe hip pain
were considered: in particular to rule out hematological
or vascular diseases which can cause bone crisis, further
investigations were performed. Chest X-ray was normal;
abdominalultrasonography showednopathologicalﬁndings
except for a slight spleen enlargement. Peripheral smear and
hemoglobin electrophoresis were normal too.
T h eM R Io ft h eh i ps h o w e dt h ep r e s e n c eo fa ne ﬀusionin
the right coxofemoral joint (Figure 1,a r r o w )a n dam a r k e d
bone marrow hyperintensity of the femoral head and neck
(Figure 1, arrowhead). Gadolinium injection (Gd-DOTA)
showed diﬀuse synovial enhancement and an inhomoge-
neous contrast enhancement in the femoral head and neck
suggestive for bone edema and in the juxtaarticular soft
tissues (Figure 2).
A f t e re x c l u d i n go t h e rp o s s i b l ec a u s e so fa c u t ep a i n / i n -
ﬂammation of the hip joint (e.g., osteomyelitis, septic arthri-
tis, sickle cell disease, haemato-oncologic disor-ders) the
coexistence of an extremely painful hip requiring narcotics,
a mild splenomegaly and MRI features resembling massive
boneedema,suggestedadiagnosisofacutebonecrisisinGD.
The diagnosis was conﬁrmed by a markedly reducedbeta
glucocerebrosidase enzyme activity in patient’s leukocytes:
genetic analysis of GBA revealed the presence of compound
heterozygosity [c1226A > G(p.N370S)]+[RecNcil].
After enzymatic replacement therapy (imiglucerase) the
patient did develop neither recurrence of bone disease nor
other clinical manifestations related to GD.
2.Discussion
GD is a lysosomal storage disorder caused by deﬁciency of
theenzymebetaglucocerebrosidase,leadingtoaccumulation
of glucocerebroside within tissue macrophages in multiple
organs. Type 1, non-neuronopathic, is the most common
form whilst types II and III are neuronopathic subtypes,
more rare, with acute and subacute onset, respectively.
Although GD has typically been described as an adult
disorder aﬀecting mainly Ashkenazi Jews, 49% of GD type
I cases are diagnosed before 10years of age and an additional
17% between 11 and 20years of age [1].
Hepatosplenomegaly, anemia, leukocytopenia,thrombo-
cytopenia are the pivotal clinical manifestations.
Skeletal involvement, another important clinical feature
of GD, is the most painful and debilitating symptom of the
disease [2].
Nonetheless, the wide heterogeneity of onset symptoms
of GD should always be ﬁrmly stressed.
In our patient the GD onset was particularly unusual
because the osteoarticular symptom was a the only clinicalArthritis 3
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Figure 2:Coronal TSE T1 fatsat(TR 500/TE 18) with fat saturationacquired after MdC injection (Gd-DOTA). Evidence ofdiﬀuse articular
synovial enhancement (arrows) of the right hip. Inhomogeneous CE is also evident in the femoral head and neck, related to bone marrow
oedema, and in the periarticular soft tissues.
symptom; moreover the absence of both peripheral cytope-
nia and signiﬁcant liver/spleen enlargement could have been
a cause of misdiagnosing or diagnostic delay [3].
In summary, our patient’s illness began as bone crisis.
As known, bone crises are acute episodes of severe skeletal
pain and fever accompanied by leucocytosis and elevated
erythrocyte sedimentation rates.
Pediatric diseases that occur with a bone crisis are rather
unusual: among these, there are hemato-oncologic diseases
(e.g.,sicklecell disease, myelodysplastic syndromes) and GD.
Although bone crises are common in GD, they rarely are the
presenting and only symptom of the disease, as in our case.
Many other diseases (trauma, orthopedic diseases, infec-
tions such as acute osteomyelitis or septic arthritis, rheuma-
tologic, or neurologic diseases) may present with symptoms
thatcanmimicabonecrisis,thereforeathoroughdiﬀerential
diagnosis is requested, particularly in otherwise healthy
children.
It is worth noting that the bone crisis is mainly char-
acterized by the excruciating pain that does not respond to
NSAIDs.
Moreover, MRI evaluation may represent a further
diagnostic tool. In particular, in our experience the ﬁndings
of an increased T2-weighted signal and an inhomogeneous
contrast enhancement at femoral head and neck were strictly
suggestive for bone crisis.
Recently the International Collaborative Gaucher Group
reported that 63% of patients experience bone pain and 26%
develop bone crisis.
Major skeletal abnormalities evident at radiographic
examinations are Erlenmeyer ﬂask deformity or bone mar-
row inﬁltration (nearly 60%), osteopenia (50%), and bone
infarction or avascular necrosis (33%).
At the time of diagnosis, children with GD type I show a
high prevalence of bone disease (radiological bone disease is
reported in 81% of cases, bone pain in 27% and bone crisis
in9%), probablystill underestimated because bone disease is
rarely evidentonphysicalexamination andmaynotcorrelate
with the degree of visceral and haematological involvement
[4].
Bone marrow inﬁltration may be responsible for
osteonecrosis and aﬀects predominantly femoral head, prox-
imal humerus, and vertebral bodies leading to fractures and
joint collapse.
Osteopenia and cortical thinning is likely related to
increased osteoclast activation by delivery of proinﬂamma-
tory cytokine from storage cells which inﬁltrate bone.
Finallybonedeformitiesofthedistalfemurandpr o ximal
tibia are due to defect in remodelling. The pathophysiology
of inﬂammatory bone disease in GD remains poorly under-
stood. Indeed,it is thoughtthat the bonemarrow inﬁltration
by Gaucher cells, that is, lipid-engorged machrophages, may4 Arthritis
cause a localized inﬂammation leading to infarction and
osteonecrosis, osteosclerosis, and osteolysis [5].
Moreover it is known that in Gaucher disease there are
signs of cytokine-mediated systemic inﬂammation and an
imbalance between osteoclast/osteoblast activities: notably
increased plasma levels of interleukin-6 have been docu-
mented in GD patients [6].
Inconclusion,ourexperienceshowsthatGDmaypresent
in atypical way and simulate a relatively common condition
in children such as acute hip joint pain.
Moreover, the early recognition of GD can start safe
and eﬀective treatment with enzyme replacement which can
decrease morbidity and reduce as far as possible the visceral
and skeletal involvement.
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